[{"address1": "4370 La Jolla Village Drive", "address2": "Suite 1050", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 225 7696", "website": "https://aardvarktherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Tien-Li  Lee M.D.", "age": 50, "title": "CEO, Secretary & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 703099, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bryan  Jones Ph.D.", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 467437, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manasi Sinha Jaiman M.D., M.P.H.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 503943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nelson B. Sun M.B.A.", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy J. Kieffer Ph.D.", "age": 58, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian  Zapf J.D.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dvorit  Samid Ph.D.", "title": "Executive Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zhenhuan  Zheng Ph.D.", "title": "Chief Research Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ron  Lewis II, Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Terrie  Kellmeyer Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.51, "open": 14.59, "dayLow": 14.045, "dayHigh": 14.75, "regularMarketPreviousClose": 14.51, "regularMarketOpen": 14.59, "regularMarketDayLow": 14.045, "regularMarketDayHigh": 14.75, "payoutRatio": 0.0, "forwardPE": -3.9324837, "volume": 102031, "regularMarketVolume": 102031, "averageVolume": 195786, "averageVolume10days": 115560, "averageDailyVolume10Day": 115560, "bid": 13.13, "ask": 13.26, "bidSize": 1, "askSize": 1, "marketCap": 310704608, "fiftyTwoWeekLow": 4.88, "fiftyTwoWeekHigh": 19.58, "allTimeHigh": 19.58, "allTimeLow": 4.88, "fiftyDayAverage": 11.9599, "twoHundredDayAverage": 11.349175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 184899584, "profitMargins": 0.0, "floatShares": 11102845, "sharesOutstanding": 21773272, "sharesShort": 1512145, "sharesShortPriorMonth": 1099118, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0695, "heldPercentInsiders": 0.14552, "heldPercentInstitutions": 0.53349996, "shortRatio": 6.56, "shortPercentOfFloat": 0.1065, "impliedSharesOutstanding": 21773272, "bookValue": 5.628, "priceToBook": 2.5355368, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -48772000, "trailingEps": -2.53, "forwardEps": -3.62875, "enterpriseToEbitda": -3.46, "52WeekChange": 0.013976216, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 14.27, "targetHighPrice": 50.0, "targetLowPrice": 18.0, "targetMeanPrice": 32.7, "targetMedianPrice": 31.0, "recommendationMean": 1.18182, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 126350000, "totalCashPerShare": 5.803, "ebitda": -53437000, "totalDebt": 545000, "quickRatio": 11.769, "currentRatio": 12.035, "debtToEquity": 0.445, "returnOnAssets": -0.30806, "returnOnEquity": -0.48061, "freeCashflow": -25479376, "operatingCashflow": -45089000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AARD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Aardvark Therapeutics, Inc.", "longName": "Aardvark Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1767995136, "regularMarketTime": 1767992401, "exchange": "NMS", "messageBoardId": "finmb_614979892", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.65403, "regularMarketPrice": 14.27, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1739457000000, "postMarketChangePercent": 0.0, "postMarketPrice": 14.27, "postMarketChange": 0.0, "regularMarketChange": -0.24, "regularMarketDayRange": "14.045 - 14.75", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 195786, "fiftyTwoWeekLowChange": 9.39, "fiftyTwoWeekLowChangePercent": 1.9241804, "fiftyTwoWeekRange": "4.88 - 19.58", "fiftyTwoWeekHighChange": -5.3099995, "fiftyTwoWeekHighChangePercent": -0.27119508, "fiftyTwoWeekChangePercent": 1.3976216, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.53, "epsForward": -3.62875, "epsCurrentYear": -2.9525, "priceEpsCurrentYear": -4.8331923, "fiftyDayAverageChange": 2.3101006, "fiftyDayAverageChangePercent": 0.19315384, "twoHundredDayAverageChange": 2.920825, "twoHundredDayAverageChangePercent": 0.2573601, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-02-13", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Aardvark Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]